The CEO Diary with Fexingo · 2026-07-16 · 11 min
In this episode of The CEO Diary, Lucas and Luna explore how Novo Nordisk transformed from a century-old Danish insulin maker into the world's most valuable pharmaceutical company, driven by its GLP-1 drugs Ozempic and Wegovy. They trace the strategic decisions by CEO Lars Fruergaard Jørgensen that turned a diabetes drug into a blockbuster weight-loss treatment, navigating supply shortages, pricing debates, and a massive manufacturing expansion. The hosts discuss how Novo Nordisk's 2025 market cap surpassed the entire Danish GDP, the company's $6.5 billion investment in new production facilities, and the competitive threat from Eli Lilly's Zepbound. They also examine the broader implications for obesity care, including the potential for GLP-1s to reduce healthcare costs and the ethical questions around drug pricing. A focused look at how one company reshaped global health and the pharmaceutical industry. #NovoNordisk #Ozempic #Wegovy #GLP1 #ObesityDrugs #LarsFruergaardJørgensen #PharmaceuticalIndustry #WeightLoss #Diabetes #DrugPricing #EliLilly #Zepbound #Healthcare #Denmark #Biotech #Business #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo
Other episodes covering the same guests and topics, from across The B2B Podcast Index.
The Future of Healthcare with Dr. David Shulkin, former Secretary of the United States Department of Veterans Affairs Part 2Pharma Sessions · on GLP-1 drugs89 / 100
James Peyer, Founder @ CambrianVenture Passport · on GLP-1 drugs83 / 100
How to Use an Operations Mindset to Scale Product DeliveryThe Product Manager · on GLP-1 drugs81 / 100
OUT OF SCOPE, Ep. 1: Hot Takes Roundtable with Tori Pastore (Soup) and Austin Campbell (Zero Knowledge)Validated · on GLP-1 drugs80 / 100
Episode 124: Annie Lamont on Healthcare, AI, Epic, Medicaid, and the Future of American MedicineThe Puck: Venture Capital and Beyond · on GLP-1 drugs79 / 100
GLP-1s and SNAP Changes Are Rewriting Grocery Merchandising | Spotlight SeriesRetail Technology Spotlight Series · on GLP-1 drugs79 / 100
How Jorgen Vig Knudstorp Saved LEGO from the Brick52 / 100How Indra Nooyi Remade PepsiCo for the Long Term70 / 100How Pixar Saved Itself from Disney and Then Saved Disney73 / 100How Ford CEO Jim Farley Bet the Company on EVs with a Fleet of Mustangs76 / 100
How Nvidia Reinvented Its Business Model Twice65 / 100